Elsie Biotechnologies

Elsie Biotechnologies, now part of GSK, carried the lab’s P(V) chemistry toward oligonucleotide medicines; its scientists co-authored the P(V) oligonucleotide platform and its improved successor.

San Diego, California · A GSK company since 2024

Papers together
3
Years
2021–2025
Co-authors
12
The record

All 3 papers with Elsie Biotechnologies

All partners →
  1. An Improved P(V) Thio-Oligonucleotide Synthesis Platform

    Org. Lett. 2025 · doi:10.1021/acs.orglett.4c03980 · In our publications

  2. Nature Chose Phosphates and Chemists Should Too: How Emerging P(V) Methods Can Augment Existing Strategies

    ACS Cent. Sci. 2021 · doi:10.1021/acscentsci.1c00487 · In our publications

    • Bristol Myers Squibb Ivar M. McDonald, Martin D. Eastgate, Michael A. Schmidt
    • Elsie Biotechnologies Dillon T. Flood, Kyle W. Knouse
  3. A P(V) Platform for Oligonucleotide Synthesis

    Science 2021 · doi:10.1126/science.abi9727 · In our publications

    • Bristol Myers Squibb Bin Zheng, Ivar M. McDonald, Martin D. Eastgate, Michael A. Schmidt, Richard E. Olson, Shenjie Qiu, Stephen E. Mercer, Yazhong Huang
    • Elsie Biotechnologies Bin Zheng, Ivar M. McDonald, Kyle W. Knouse, Martin D. Eastgate, Michael A. Schmidt, Richard E. Olson, Shenjie Qiu, Stephen E. Mercer, Yazhong Huang

Our co-authors at Elsie Biotechnologies

Martin D. EastgateDillon T. FloodYazhong HuangYonghao JinKyle W. KnouseIvar M. McDonaldStephen E. MercerRichard E. OlsonShenjie QiuRichard L. RedmanMichael A. SchmidtBin Zheng

Some of these papers were shared with 3 other partners: Hongene Biotech, Socrates Biosciences, Bristol Myers Squibb.

Work with us

Interested in collaborating with the Baran lab?

If your team has a problem that matters, a molecule no one can make, a reaction that will not scale, a reagent that should exist, we would love to hear about it.

Email Phil

or write to pbaran@scripps.edu